# Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

> **NCT05873218** · PHASE4 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 100 (estimated)

## Conditions studied

- Labor

## Interventions

- **DRUG:** Ephedrine
- **DRUG:** Normal Saline Placebo

## Key facts

- **NCT ID:** NCT05873218
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-26
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05873218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05873218, "Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05873218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*